Patents/Assignees

Gilead Sciences, Inc.

201 patents in portfolio

USD0985398design2023
Blister Pack
0 cites
US11642361utility2023
Nucleoside Phosphoramidate Prodrugs
0 cites
US11643400utility2023
MCL-1 Inhibitors
0 cites
US11634505utility2023
Antibodies to Matrix Metalloproteinase 9
0 cites
US11613546utility2023
Substituted Pyridotriazine Compounds and Uses Thereof
0 cites
US11613553utility2023
Methods of Preparing 1′-cyano Nucleosides
0 cites
US11597742utility2023
Crystalline Forms of (s)-2-ethylbutyl 2-(((s)-(((2r,3s,4r,5r)-5-(4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy) (phenoxy) Phosphoryl)amino)propanoate
0 cites
US11597759utility2023
Multispecific Antibodies That Target HIV GP120 and CD3
0 cites
USD0979401design2023
Blister Pack Packaging Blank
0 cites
US11583531utility2023
Solid Forms of a Toll-like Receptor Modulator
0 cites
US11583581utility2023
Methods of Treating a Retroviral Infection
0 cites
US11584738utility2023
LPA Receptor Antagonists and Uses Thereof
0 cites
US11578069utility2023
Compounds for Inhibition of Α4 Β7 Integrin
0 cites
US11578117utility2023
Antibodies and Fragments Thereof That Bind Hepatitis B Virus Protein X
0 cites
US11578331utility2023
Combination Comprising Immunostimulatory Oligonucleotides
0 cites
US11572362utility2023
Pyrrolo[1,2-b]pyridazine Derivatives
0 cites
US11555029utility2023
PD-1/PD-L1 Inhibitors
0 cites
US11548871utility2023
Triazole Carbamate Pyridyl Sulfonamides as LPA Receptor Antagonists and Uses Thereof
0 cites
US11548901utility2023
Substituted 1,4-methanopyrido[1′,2′:4,5]pyrazino[1,2-a]pyrimidines for Treating Viral Infections
0 cites
US11548902utility2023
Bridged Tricyclic Carbamoylpyridone Compounds and Their Pharmaceutical Use
0 cites

← PreviousPage 10 of 11Next →